Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treat or palliate: outcomes of very elderly myeloma patients.
Panitsas F, Kothari J, Vallance G, Djebbari F, Ferguson L, Sultanova M, Ramasamy K. Panitsas F, et al. Among authors: vallance g. Haematologica. 2018 Jan;103(1):e32-e34. doi: 10.3324/haematol.2017.173617. Epub 2017 Oct 12. Haematologica. 2018. PMID: 29025911 Free PMC article. No abstract available.
Clinical outcomes of bortezomib-based therapy in myeloma.
Djebbari F, Srinivasan A, Vallance G, Moore S, Kothari J, Ramasamy K. Djebbari F, et al. Among authors: vallance g. PLoS One. 2018 Dec 12;13(12):e0208920. doi: 10.1371/journal.pone.0208920. eCollection 2018. PLoS One. 2018. PMID: 30540831 Free PMC article.
Carfilzomib therapy for relapsed myeloma: results of a UK multicentre experience.
Djebbari F, Hubenov H, Neelakantan P, Wolf J, Offer M, Khera A, Louka E, Vallance G, Kothari J, Moore S, Ramasamy K. Djebbari F, et al. Among authors: vallance g. Br J Haematol. 2020 Feb;188(4):e57-e60. doi: 10.1111/bjh.16324. Epub 2019 Dec 2. Br J Haematol. 2020. PMID: 31792927 Free article. Clinical Trial. No abstract available.
[No title available]
[No authors listed] [No authors listed] PMID: 31919073
Real-world effectiveness and safety of ixazomib-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma.
Terpos E, Ramasamy K, Maouche N, Minarik J, Ntanasis-Stathopoulos I, Katodritou E, Jenner MW, Plonkova H, Gavriatopoulou M, Vallance GD, Pika T, Kotsopoulou M, Kothari J, Jelinek T, Kastritis E, Aitchison R, Dimopoulos MA, Zomas A, Hajek R. Terpos E, et al. Ann Hematol. 2020 May;99(5):1049-1061. doi: 10.1007/s00277-020-03981-z. Epub 2020 Apr 1. Ann Hematol. 2020. PMID: 32236735 Clinical Trial.
Integrating clinical features with genetic factors enhances survival prediction for adults with acute myeloid leukemia.
Silveira DRA, Quek L, Santos IS, Corby A, Coelho-Silva JL, Pereira-Martins DA, Vallance G, Brown B, Nardinelli L, Silva WF, Velloso EDRP, Lucena-Araujo AR, Traina F, Peniket A, Vyas P, Rego EM, Bendit I, Rocha V. Silveira DRA, et al. Among authors: vallance g. Blood Adv. 2020 May 26;4(10):2339-2350. doi: 10.1182/bloodadvances.2019001419. Blood Adv. 2020. PMID: 32453839 Free PMC article.
A multicenter comparative acute myeloid leukemia study: can we explain the differences in the outcomes in resource-constrained settings?
Silveira DRA, Coelho-Silva JL, Silva WF, Vallance G, Pereira-Martins DA, Madeira MIA, Figueredo-Pontes LL, Velloso EDRP, Simões BP, Peniket A, Danby R, Rego EM, Vyas P, Traina F, Bendit I, Quek L, Rocha V. Silveira DRA, et al. Among authors: vallance g. Leuk Lymphoma. 2021 Jan;62(1):147-157. doi: 10.1080/10428194.2020.1827252. Epub 2020 Sep 30. Leuk Lymphoma. 2021. PMID: 32996373
Infection-related morbidity in a large study of transplant non-eligible newly diagnosed myeloma patients treated with UK standard of care.
Djebbari F, Panitsas F, Eyre TA, Prodger C, Davies F, Burton K, Khera A, Vallance G, Moore S, Kothari J, Peniket A, Ramasamy K. Djebbari F, et al. Among authors: vallance g. Haematologica. 2020 Sep 1;105(9):e474-479. doi: 10.3324/haematol.2019.240762. Haematologica. 2020. PMID: 33054067 Free PMC article. No abstract available.
24 results